SUPERNUS PHARMACEUTICALS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $210.1m $294.1m $408.9m $392.8m $520.4m $579.8m $667.2m $607.5m $661.8m $719.0m
Cost of Revenue $12.0m $15.2m $15.4m $16.7m $52.5m $75.1m $87.2m $83.8m $77.9m $74.6m
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization $75.1m $87.2m
Gross Profit (Calculated) (derived) $203.0m $287.0m $393.5m $376.1m $467.9m $504.7m $580.0m $523.7m $583.9m $644.4m
Operating expenses:
Operating Income (Loss) $54.2m $99.5m $144.4m $148.6m $173.7m $86.0m $46.1m ($5.3m) $81.7m ($62.3m)
Additional Financial Items
Amortization of Intangible Assets $1.3m $6.9m $5.2m $5.2m $15.7m $30.0m $82.6m $82.4m $78.0m $89.5m
Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded $0 $0 $0
Goodwill, Impairment Loss $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($48.8m)
Interest Income, Other $21.6m $18.7m
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss ($8k)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $50.4m $100.6m $140.2m $147.5m $168.6m $73.2m $60.7m $2.8m $97.9m ($49.0m)
Gain (Loss) on Derivative Instruments, Net, Pretax $448k $76k
Net Income (Loss) Attributable to Parent $91.2m $57.3m $111.0m $113.1m $127.0m $53.4m $60.7m $1.3m $73.9m ($38.5m)
Net Income (Loss) Available to Common Stockholders, Basic $91.2m $57.3m $111.0m $113.1m $127.0m $53.4m $64.3m $1.3m $73.9m ($38.5m)
Earnings Per Share, Basic $1.84 $1.13 $2.13 $2.16 $2.41 $1.01 $1.13 $0.02 $1.34 ($0.68)
Earnings Per Share, Diluted $1.76 $1.08 $2.05 $2.10 $2.36 $0.98 $1.04 $0.02 $1.32 ($0.68)
Weighted Average Number of Shares Outstanding, Basic 49.5m 50.8m 52.0m 52.4m 52.6m 53.1m 53.7m 54.5m 55.1m 56.5m
Weighted Average Number of Shares Outstanding, Diluted 51.7m 53.3m 54.1m 53.8m 53.7m 54.4m 61.7m 55.5m 56.0m 56.5m
Research and Development Expense $42.8m $49.6m $89.2m $69.1m $76.0m $90.5m $74.6m $91.6m $108.8m $106.2m
Selling, General and Administrative Expense $106.0m $137.9m $159.9m $158.4m $200.7m $304.8m $377.2m $336.4m $321.6m $485.6m
Other Nonoperating Income (Expense) ($15k) ($1.1m) ($5.0m) ($12.9m) $14.6m $10.5m $16.2m $13.3m
Interest Expense (non-operating) $2.4m $0 $0
Costs and Expenses $160.8m $202.7m $264.5m $244.2m $346.7m $493.7m $621.1m $612.8m $580.2m $781.2m
Current Income Tax Expense (Benefit) ($600k) ($15.7m)
Interest Expense $543k $134k $13.8m $18.2m $19.4m $19.7m
Interest Expense, Debt $4.7m $1.3m $0 $0
Income Tax Expense (Benefit) ($40.9m) $43.3m $29.2m $34.4m $41.7m $19.8m $32k $1.5m $24.0m ($10.5m)
Interest Revenue (Expense), Net $16.0m $8.8m